We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
CleanSpark
CLSK
$3.16B
| $490K | ﹤0.01% |
42,316
+1,615
| +4% | +$21.7K |
|
2552
Oramed Pharmaceuticals
ORMP
$179M
| $488K | ﹤0.01% |
22,223
+8,241
| +59% | +$140K |
|
|
SFT
2553
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $488K | ﹤0.01% |
7,039
+255
| +4% | +$20.4K |
|
|
NESR
2554
National Energy Services Reunited Corp
NESR
$2.93B
| $486K | ﹤0.01% |
38,845
+8,230
| +27% | +$100K |
|
2555
N-able
NABL
$940M
| $485K | ﹤0.01% |
+39,104
| New | +$536K |
|
2556
Rocky Brands
RCKY
$369M
| $485K | ﹤0.01% |
10,178
+125
| +1% | +$6.21K |
|
2557
First Advantage
FA
$4.12B
| $484K | ﹤0.01% |
+25,384
| New | +$533K |
|
|
RMO
2558
DELISTED
Romeo Power, Inc.
RMO
| $484K | ﹤0.01% |
97,740
+57,757
| +144% | +$345K |
|
2559
Aemetis
AMTX
$124M
| $482K | ﹤0.01% |
26,365
+3,806
| +17% | +$42.1K |
|
2560
AXT Inc
AXTI
$5.8B
| $482K | ﹤0.01% |
57,887
+919
| +2% | +$8.56K |
|
|
BHR
2561
Braemar Hotels & Resorts
BHR
$142M
| $482K | ﹤0.01% |
99,301
+57,286
| +136% | +$299K |
|
2562
Capital City Bank Group
CCBG
$890M
| $482K | ﹤0.01% |
19,473
+383
| +2% | +$9.12K |
|
|
CLVS
2563
DELISTED
Clovis Oncology, Inc.
CLVS
| $482K | ﹤0.01% |
107,983
+2,411
| +2% | +$11.6K |
|
|
AMNB
2564
DELISTED
American National Bankshares Inc
AMNB
| $481K | ﹤0.01% |
14,560
+310
| +2% | +$9.94K |
|
|
ICPT
2565
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $480K | ﹤0.01% |
32,354
+1,001
| +3% | +$16K |
|
2566
SmartFinancial
SMBK
$888M
| $479K | ﹤0.01% |
18,526
+402
| +2% | +$9.93K |
|
|
SNCY
2567
DELISTED
Sun Country Airlines
SNCY
| $479K | ﹤0.01% |
14,288
+802
| +6% | +$26.7K |
|
2568
Kartoon Studios
TOON
$34.9M
| $478K | ﹤0.01% |
35,175
+1,126
| +3% | +$17.5K |
|
|
IVC
2569
DELISTED
Invacare Corporation
IVC
| $478K | ﹤0.01% |
100,514
-13,231
| -12% | -$96.6K |
|
2570
Primis Financial Corp
FRST
$404M
| $477K | ﹤0.01% |
32,977
+1,322
| +4% | +$19.8K |
|
|
ONTF
2571
DELISTED
ON24
ONTF
| $473K | ﹤0.01% |
23,744
+15,766
| +198% | +$438K |
|
2572
Cue Biopharma
CUE
$114M
| $472K | ﹤0.01% |
1,080
+46
| +4% | +$16K |
|
2573
Q32 Bio
QTTB
$464M
| $472K | ﹤0.01% |
3,334
+47
| +1% | +$5.99K |
|
2574
Artesian Resources
ARTNA
$358M
| $469K | ﹤0.01% |
12,284
+309
| +3% | +$11.9K |
|
2575
Omega Flex
OFLX
$312M
| $469K | ﹤0.01% |
3,287
+117
| +4% | +$17.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.